Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sniffing geranium oil may ease chemo sickness

NCT ID NCT07292831

Symptom relief Sponsor: Universitas Muhammadiyah Surakarta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether inhaling geranium essential oil can reduce nausea and vomiting in cancer patients receiving chemotherapy. 90 participants were randomly assigned to either inhale geranium oil during chemo or receive no aromatherapy. Nausea and vomiting were measured before and 12 hours after treatment using a standard scale.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
geranium essential oil (Pelargonium graveolens) via inhalation
What this could lead to
If it works, this could offer a simple, drug-free way to help cancer patients feel less sick during chemotherapy.
What could go wrong
This is a small, completed trial with no phase designation. Results may not be strong enough to change practice, and the effect could be due to placebo or the calming ritual of inhalation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jan 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosed with cancer. 2. Currently undergoing intravenous chemotherapy regimen 1. 3. Aged under 65 years. 4. Body Mass Index (BMI) between 18.5 and 22.9 kg/m². 5. Able and willing to provide informed consent. 6. Able to communicate and follow study instructions. Exclusion Criteria: Known allergy or sensitivity to essential oils or fragrances

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer chemotherapy-induced toxicity Nausea neoplasm Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Chemotherapy-induced nausea and vomiting (CINV)

Contacts and locations

Locations

  • RSUD Dr. Moewardi Surakarta

    Surakarta, Centre Java, 57126, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.